Franklin Resources Inc Sanofi Transaction History

Franklin Resources Inc

$346 Billion
Q3 2024

A detailed history of Franklin Resources Inc transactions in Sanofi stock. As of the latest transaction made, Franklin Resources Inc holds 8,958,620 shares of SNY stock, worth $428 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

8,958,620

Previous 3,011,708 197.46%

Holding current value

$428 Million

Previous $146 Million 253.49%

% of portfolio

0.15%

Previous 0.05%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$48.54 - $58.53 $289 Million - $348 Million	5,946,912 Added 197.46%	8,958,620 $517 Million
Q2 2024 Aug 14, 2024	BUY	$45.39 - $50.36 $67 Million - $74.4 Million	1,477,091 Added 96.25%	3,011,708 $146 Million
Q1 2024 May 13, 2024	BUY	$45.75 - $52.48 $64.5 Million - $73.9 Million	1,409,030 Added 1121.96%	1,534,617 $74.6 Million
Q4 2023 Feb 09, 2024	SELL	$43.13 - $54.79 $331,367 - $420,951	-7,683 Reduced 5.76%	125,587 $6.25 Million
Q3 2023 Nov 13, 2023	SELL	$50.95 - $55.2 $2,700 - $2,925	-53 Reduced 0.04%	133,270 $7.15 Million
Q2 2023 Aug 11, 2023	BUY	$50.45 - $57.18 $305,575 - $346,339	6,057 Added 4.76%	133,323 $7.19 Million
Q1 2023 May 12, 2023	BUY	$45.86 - $54.45 $1.15 Million - $1.37 Million	25,106 Added 24.58%	127,266 $6.93 Million
Q4 2022 Feb 10, 2023	BUY	$38.86 - $48.55 $2.08 Million - $2.6 Million	53,477 Added 109.85%	102,160 $4.95 Million
Q3 2022 Nov 14, 2022	SELL	$37.22 - $100.5 $11,314 - $30,552	-304 Reduced 0.62%	48,683 $1.85 Million
Q2 2022 Aug 11, 2022	BUY	$48.99 - $57.46 $43,111 - $50,564	880 Added 1.83%	48,987 $2.45 Million
Q1 2022 May 13, 2022	BUY	$48.48 - $53.65 $251,320 - $278,121	5,184 Added 12.08%	48,107 $2.47 Million
Q4 2021 Feb 11, 2022	SELL	$47.07 - $52.35 $19,863 - $22,091	-422 Reduced 0.97%	42,923 $2.15 Million
Q3 2021 Nov 12, 2021	BUY	$47.89 - $53.12 $155,498 - $172,480	3,247 Added 8.1%	43,345 $2.09 Million
Q2 2021 Aug 13, 2021	SELL	$49.36 - $54.25 $1.83 Million - $2.01 Million	-37,123 Reduced 48.07%	40,098 $2.11 Million
Q1 2021 May 13, 2021	BUY	$45.46 - $50.51 $264,168 - $293,513	5,811 Added 8.14%	77,221 $3.82 Million
Q4 2020 Feb 10, 2021	SELL	$45.3 - $51.62 $1.58 Million - $1.8 Million	-34,790 Reduced 32.76%	71,410 $3.47 Million
Q3 2020 Nov 12, 2020	SELL	$49.47 - $53.77 $1.29 Million - $1.4 Million	-26,110 Reduced 19.73%	106,200 $5.33 Million
Q2 2020 Aug 13, 2020	SELL	$42.91 - $52.5 $372,802 - $456,120	-8,688 Reduced 6.16%	132,310 $7.05 Million
Q1 2020 May 13, 2020	BUY	$38.02 - $51.66 $9,733 - $13,224	256 Added 0.18%	140,998 $6.16 Million
Q4 2019 Feb 12, 2020	SELL	$44.25 - $50.86 $3.15 Million - $3.62 Million	-71,147 Reduced 33.58%	140,742 $7.07 Million
Q3 2019 Nov 14, 2019	SELL	$40.34 - $46.64 $1.12 Million - $1.3 Million	-27,807 Reduced 11.6%	211,889 $9.77 Million
Q2 2019 Aug 14, 2019	SELL	$40.43 - $44.3 $788,142 - $863,584	-19,494 Reduced 7.52%	239,696 $10.4 Million
Q1 2019 May 14, 2019	SELL	$40.83 - $45.43 $2.39 Million - $2.66 Million	-58,540 Reduced 18.42%	259,190 $11.5 Million
Q4 2018 Feb 12, 2019	SELL	$41.48 - $45.59 $289,530 - $318,218	-6,980 Reduced 2.15%	317,730 $13.8 Million
Q3 2018 Nov 13, 2018	SELL	$40.0 - $44.84 $96 Million - $108 Million	-2,400,088 Reduced 88.08%	324,710 $14.5 Million
Q2 2018 Aug 14, 2018	SELL	$37.63 - $41.22 $681 Million - $746 Million	-18,107,782 Reduced 86.92%	2,724,798 $109 Million
Q1 2018 May 10, 2018	SELL	$38.98 - $45.76 $280,032 - $328,739	-7,184 Reduced 0.03%	20,832,580 $835 Million
Q4 2017 Feb 14, 2018	SELL	$42.86 - $50.61 $1.88 Million - $2.22 Million	-43,963 Reduced 0.21%	20,839,764 $896 Million
Q3 2017 Nov 13, 2017	BUY	$47.04 - $50.34 $982 Million - $1.05 Billion	20,883,727	20,883,727 $1.04 Billion

Others Institutions Holding SNY

# of Institutions

819

Shares Held

274M

Call Options Held

Put Options Held

1.9M

View Full List

About Sanofi

Ticker SNY
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,508,100,096
Market Cap $120B
Description
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...

More about SNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.

Account

Franklin Resources Inc Sanofi Transaction History